Navigation Links
Neurocrine Biosciences To Present At The Morgan Stanley Global Healthcare Conference
Date:9/3/2014

SAN DIEGO, Sept. 3, 2014 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the Morgan Stanley Global Healthcare Conference in New York City.  

The live presentation takes place on Wednesday, September 10 at 11:30am ET (8:30am PT).  The presentation will be webcast and may be accessed on the Company's website at http://www.neurocrine.com.  

Listeners are encouraged to visit the website approximately 5 minutes prior to the presentation to download or install any necessary software.  A replay of the presentation will be available on the website approximately one hour after the conclusion of the event and will be archived for one month.

Neurocrine Biosciences, Inc. discovers and develops innovative and life-changing pharmaceuticals, in diseases with high unmet medical needs, through its novel R&D platform, focused on neurological and endocrine based diseases and disorders. The Company's two lead late-stage clinical programs are elagolix, a gonadotropin-releasing hormone antagonist for women's health that is partnered with AbbVie Inc., and a wholly owned vesicular monoamine transporter 2 inhibitor for the treatment of movement disorders. Neurocrine intends to maintain certain commercial rights to its VMAT2 inhibitor for evolution into a fully-integrated pharmaceutical company.  Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com.


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences Reports Second Quarter 2014 Results
2. Neurocrine Biosciences Announces Conference Call And Webcast To Report Second Quarter 2014 Financial Results
3. Neurocrine Announces 12-Week Safety Results From Initial Phase IIB Study Of VMAT2 Inhibitor NBI-98854
4. Healthcare Companies Report Conference Presentation Schedule, Stock Price Updates, and Clinical Study Results - Research Report on Medivation, Envision Healthcare, Fonar, Idera Pharma, and Neurocrine
5. Neurocrine Announces Positive Results of VMAT2 Inhibitor NBI-98854 in Kinect 2 Study
6. Neurocrine Biosciences To Present At Oppenheimers 24th Annual Healthcare Conference
7. Neurocrine Biosciences Announces Conference Call And Webcast To Present Third Quarter 2013 Financial Results
8. Clinical Trial Results, Litigation Outcomes and Marketing Authorizations - Research Report on Pfizer, GlaxoSmithKline, Sanofi, AstraZeneca, and Neurocrine
9. Neurocrine Announces Phase IIb Results Of VMAT2 Inhibitor NBI-98854 For Treatment Of Tardive Dyskinesia
10. Clinical Trials, New Orders, Improved Services, and Approvals - Research Report on CareFusion, St. Jude Medical, Community Health Systems, Neurocrine Biosciences, and Alnylam Pharmaceuticals
11. Neurocrine Biosciences Announces the Start of Second Phase III Study of Elagolix in Endometriosis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... Jan. 23, 2015  Pete Rose, baseball,s all-time hits leader, is ... pain reliever Myoflex, Ducere Pharma has announced. "Pete,s ... excited to have him on board with Myoflex," said Ducere ... a legendary player who is known across all generations. The ...
(Date:1/23/2015)... 2015 Cord Blood America, Inc. ( www.cordblood-america.com ) (OTC ...  filed a Preliminary Proxy Statement, Schedule 14A, with the U.S. ... an update for shareholders detailing why a "YES" vote to ... Dear Shareholders, As we reflect upon the 2014 ...
(Date:1/23/2015)... and BOSTON , January 23, 2015 ... discovery and development company, is delighted to announce that the ... awarded to Miles Congreve (Vice President of Chemistry), ... Malcolm Weir (Chief Executive Officer and co-founder) for ...
Breaking Medicine Technology:Pete Rose bets on Myoflex to relieve aches and pains 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 2Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 3Cord Blood America Announces Preliminary Proxy Filing and Details Why a "YES" Vote to Increase Authorized Shares Is Requested 4Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 2Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 3Heptares Scientists to Receive the Malcolm Campbell Memorial Prize for 2015 in Recognition of Their Outstanding Contribution to GPCR Drug Discovery 4
... Dec. 14, 2010 The Dr. Paul Janssen ... call for nominations. This prestigious award recognizes individuals ... potential to make, significant transformational contributions toward the ... www.pauljanssenaward.com and will be accepted until ...
... The DNA Medicine Institute (DMI) successfully completed reduced-gravity experiments ... to the Space Environment for Technology (FAST) program, at ... Texas, at the end of September.  The rHEALTH sensor ... from a single drop of blood.  Although designed for ...
Cached Medicine Technology:Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 2Dr. Paul Janssen Award for Biomedical Research Issues Call for Nominations 3DNA Medicine Institute Completes Reduced-Gravity Experiments on its NASA-Funded rHEALTH Sensor 2
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy ... its highest annual revenues in the past three years. Today, ... wedding dresses. , According to the sales manager of the ... for them in 2015. This point can be reflected on ...
(Date:1/22/2015)... Payday lending practices in four southern states ... distress to the states that permit them, according to ... on Race and Wealth. , While they generate hundreds ... at the same time substantially depress economic activity, according ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store for wedding dresses ... latest collection of wedding dresses , and launches a site-wide ... wedding dress on your big day; the wedding gown is ... wants to find the most suitable wedding dress. Now, we ...
(Date:1/22/2015)... Richmond, VA (PRWEB) January 22, 2015 ... the power at the Science Museum of Virginia. Wicked ... 24. , Wicked Plants unearths 75 poisonous, carnivorous and ... traverse through each room to uncover the biochemical, physical ...
(Date:12/26/2014)... 2014 It is said that nothing makes ... UWDress.com, the famous wedding dress supplier, shows its new ... cocktail gown promotion. , UWDress.com’s navy cocktail gowns are ... come in high fashion styles. Simple dresses in bright neon ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... significantly increased life expectancy in early tests of patients ... aggressive form of brain cancer in adults − is ... Clinic in Jacksonville. , The vaccine represents a fresh ... neurosurgeon Kent New, M.D., Ph.D., who will be leading ...
... Looks toward Year of Continued Rapid Growth For Retail ... ... Web Golinkin, president and CEO,of RediClinic, LLC, has been elected president ... Care,Industry (CCI). A founder of the association and its first treasurer, ...
... to Break Ground, TAMPA, Fla., Oct. 22 The ... of Tampa Bay will break ground in January of,2008, and ... Center of Tampa Bay, developed and operated by Tampa Bay,Radiosurgical ... be used by a large number of physicians from various ...
... Medicine, will appear at Sixth & I for a ... sciences and their potential to transform medical treatment. ... scientist in the United Kingdom, where he was born. ... (CDK) as the key regulator molecule controlling the process ...
... in the fight against HIV and they must be ... to a new commentary published today in the journal ... London, who are evaluating multiple candidate vaccines designed to ... must commit to sharing technology and expertise with those ...
... October 22, 2007 Today, The National Institutes of ... Science Editors global theme issue on poverty and human ... by more than 230 journals worldwide. , Many ... Science Editors campaign to encourage science journals to focus ...
Cached Medicine News:Health News:Mayo Clinic tests novel vaccine for aggressive brain tumors 2Health News:RediClinic's Web Golinkin to Lead Convenient Care Association 2Health News:Fight against HIV needs local scientists, say researchers 2Health News:Elsevier journals participate widely in global theme issue on poverty and human development 2
... Corneal Topographer has applications in ... procedures including Radial Keratotomy, Astigmatic ... Lens Fitting. Based on an ... E300 analyses an accurate ring ...
... System provides an automated scalable system capable ... SNP genotypes per day. Combined with multiplexing ... enables you to process a wide range ... designed to deliver your intended results faster ...
... including fourSight 4D ultrasound imaging technology for ... wide variety of imaging and workflow enhancements ... combine to expand the clinical capabilities for ... was built on four foundations that mark ...
... The BeStent2, a laser-cut stent, is the ... stent systems for use after coronary arteries ... a therapy known as percutaneous transluminal coronary ... a number of features designed to optimize ...
Medicine Products: